Singapore markets closed

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.9800-0.0900 (-4.35%)
As of 03:02PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5545
Avg. Estimate-0.24-0.22-0.780.04
Low estimate-0.37-0.33-0.96-0.57
High estimate-0.05-0.04-0.410.68
Year ago EPS-0.75-0.38-1.98-0.78
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6588
Avg. Estimate80.25M53.68M280.31M367.73M
Low estimate47.07M49.56M206.49M279.91M
High estimate102M68M411M513.75M
Year ago sales47.44MN/A257.24M280.31M
Sales growth (year/est)69.20%N/A9.00%31.20%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.57-0.48-0.27-0.12
Actual EPS-0.75-0.38-0.27-0.62
Difference-0.180.10-0.5
Surprise %-31.60%20.80%0.00%-416.70%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.24-0.22-0.780.04
7 days ago-0.24-0.22-0.780.04
30 days ago-0.23-0.22-0.720.07
60 days ago-0.23-0.18-0.250.01
90 days ago-0.23-0.18-0.250.01
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCHRSIndustrySector(s)S&P 500
Current qtr.68.00%N/AN/AN/A
Next qtr.42.10%N/AN/AN/A
Current year60.60%N/AN/AN/A
Next year105.10%N/AN/AN/A
Next 5 years (per annum)-25.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A